As the two industry-renowned exhibitions—CPhI North America and TIDES USA 2022 draw near, BOC Sciences is making final efforts to let the news reach as many researchers as possible, especially those who are struggling to find the best mRNA services.
BOC Sciences has prepared a long list of first-rate pseudoUridines to be presented at two industry-renowned exhibitions—CPhI North America and TIDES USA 2022.
Lately, BOC Sciences projects a webinar themed as Targeting RNA Structure as a Therapeutic Strategy, awaiting broad participation on January 19th, 2022.
As a professional medicinal chemistry expert as well as a leading practitioner, BOC Sciences recently rearranges its relevant business, aiming to provide excellent analysis and purification service for scientists who are carrying out drug discovery projects.
BOC Sciences recently announces to enhance its one-stop compound screening platform, which is efficient, economical and systematic, aiming to help scientists fulfill their screening needs arising from drug R&D projects.
BOC Sciences announces to upgrade its already well-established bioconjugation service by extending the business range to biomolecule labeling, antibody conjugation, as well as other conjugation services.
BOC Sciences announces to continuously improve its Superparamagnetic Iron Oxide Nano/Micro Particles Preparation service for researchers who are engaged with chemotherapy study.
BOC Sciences, one of the major chemical providers, announced to newly introduce dozens of IDO inhibitors in order to facilitate facilitating researchers’ efforts in drug discovery and drug design both academically and industrially.
Satisfied Users & 
Approved Press Releases
